Stocks
Vanda Pharmaceuticals (VNDA) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | 10.7% | 12.1% | 16.2% | 3.08% | -5.68% | -14.7% | |
| Changes by years, y/y, % | -1pp | +1pp | +4pp | -13pp | -9pp | |||
Vanda Pharmaceuticals. EBITDA margin, %
Vanda Pharmaceuticals. EBITDA margin, changes, pp
Vanda Pharmaceuticals (VNDA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EBITDA margin, % | ? | -5.40% | -14.5% | -13.1% | -14.8% | -16.2% | -14.7% | |
| Changes by years, y/y, % | -12pp | -21pp | -24pp | -19pp | -11pp | |||
| Changes by quarters, q/q, % | -10pp | -9pp | +1pp | -2pp | -1pp | |||
